Revised: 26 August 2026
Medicines
Medsafe Product Detail |
||
|---|---|---|
| File ref: TT50-4804 |
| Trade Name | Dose Form | Strength | Identifier |
|---|---|---|---|
| Ped-el sterile | Solution for injection | see composition | |
| Sponsor | Application date | Regulatory status | Classification |
| Pfizer New Zealand Limited Level 3, Pfizer House 14 Normanby Road Mt Eden AUCKLAND |
21/06/1990 | Approval lapsed Approval date:21/06/1990 Notification date: 28/11/2012 |
General sale |
Composition
| Component | Ingredient | Manufacturer |
|---|---|---|
| solution for injection | Active | |
| Calcium chloride dihydrate 22.06 mg/mL | ||
| Copper chloride dihydrate 12.8 µg/mL | ||
| Ferric chloride hexahydrate 135 µg/mL | ||
| Magnesium chloride hexahydrate 5.08 mg/mL | ||
| Manganese chloride tetrahydrate 49.5 µg/mL | ||
| Phosphoric acid 8.65 mg/mL | ||
| Potassium iodide 1.7 µg/mL | ||
| Sodium fluoride 31.5 µg/mL | ||
| Zinc chloride 20.4 µg/mL |
Production
| Manufacturing step | Manufacturer |
|---|---|
| Manufacture of Final Dose Form | Recipharm Karlskoga AB Lindhagensgatan 133 Stockholm SE-11 287 SWEDEN |
| Packing | Recipharm Karlskoga AB Lindhagensgatan 133 Stockholm SE-11 287 SWEDEN |
| NZ Site of Product Release | No site specified |
Packaging
| Package | Contents | Shelf life |
|---|---|---|
| Vial, | 20 mL | 24 months from date of manufacture stored at 8° to 15°C (Cool) |
